ACTIVE SUBSTANCE / INN

TOVORAFENIB

Brand name(s): Ojemda, OJEMDA
FDA LISTED
EMA LISTED
PRESCRIPTION
OPINION
Glioma
NDA218033
ACTIVE SUBSTANCE
Tovorafenib
REGULATORS
FDA · EMA
SPONSORS / MAH
DAY ONE BIOPHARMS, Ipsen Pharma
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OJEMDANDA218033DAY ONE BIOPHARMSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OjemdaIpsen PharmaOpinionGlioma

FULL INTELLIGENCE ON TOVORAFENIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →